News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Novel Drug Promising as Metformin Add-on
June 25, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MedPage Today -- Adding dapagliflozin, an investigational selective sodium-glucose cotransporter-2 (SGLT2) inhibitor, to metformin may improve glycemic control in diabetic patients who aren't responsive to metformin monotherapy.
Twitter
LinkedIn
Facebook
Email
Print